Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × cabazitaxel × Clear all

Phase

Status

Recruiting 2 Completed 1 Active not recruiting 1

Sponsor Class

OTHER 26 INDUSTRY 19 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 183 Cisplatin 159 Cyclophosphamide 140 Doxorubicin 111 Paclitaxel 106 Vincristine 101 Filgrastim 97 Etoposide 87 Carboplatin 87 Gemcitabine 70 Methotrexate 67 Docetaxel 66 Gene Expression Profiling 64 Fluorouracil 64 Cytarabine 62 Prednisone 58 Dexamethasone 58 Granulocyte Colony-Stimulating Factor 53 Leucovorin 51 Polymerase Chain Reaction 40 Immunohistochemistry 39 Microarray Analysis 37 Ifosfamide 33 Daunorubicin 33 Irinotecan 32 Temozolomide 30 Cetuximab 28 Amplified Fragment Length Polymorphism Analysis 28 Capecitabine 27 Flow Cytometry 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01913652 2021-09-14

Ph II Cabazitaxel DD Liposarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡